Abstract
Current adenoviral (Ad) vectors cannot be targeted to specific cell types due to the widespread distribution of the Ad receptor (CAR). Moreover, CAR and/or internalization receptors (αv integrins) are absent or present at low levels on some cell types, rendering them resistant to Ad-mediated gene delivery. To address these problems, we have developed a novel vector targeting approach that takes advantage of the common cell signaling pathways initiated by ligation of αv integrins and growth factor receptors. Recombinant growth factor/cytokines (TNF-α, IGF-1, EGF) which trigger phosphatidylinositol-3-OH kinase (PI3K) activation, a signaling molecule involved in adenovirus internalization, were fused to a monoclonal antibody specific for the viral penton base. Ad vectors complexed with these bifunctional mAbs increased gene delivery 10 to 50-fold to human melanoma cells lacking αv integrins. The bifunctional mAbs also enhanced gene delivery by fiberless adenovirus particles which cannot bind to CAR. Improved gene delivery correlated with increased virus internalization and attachment as well as PI3K activity. The use of bifunctional mAbs to trigger specific cell signaling pathways offers a widely applicable method for bypassing the normal Ad receptors in gene delivery and potentially increasing the selectivity of gene transfer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bilbao G et al. Targeted adenoviral vectors for cancer gene therapy Adv Exp Med Biol 1998 451: 365–374
Gomez-Navarro J et al. Gene therapy for cancer Eur J Cancer 1999 35: 867–885
Kay MA et al. Gene therapy Proc Natl Acad Sci USA 1997 94: 12744–12746
Bergelson JM et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 Science 1997 275: 1320–1323
Tomko RP et al. HCAR and MAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses Proc Natl Acad Sci USA 1997 94: 3352–3356
Wickham TJ et al. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment Cell 1993 73: 309–319
Zabner J et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis Cell 1993 75: 207–216
Crystal RG et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis Nat Genet 1994 8: 42–51
Goldman MJ, Wilson JM . Expression of αvβ5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway J Virol 1995 69: 5951–5958
Grubb BR et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans Nature 1994 371: 802–806
Krasnykh VN et al. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism J Virol 1996 70: 6839–6846
Vigne E et al. RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection J Virol 1999 73: 5156–5161
Watkins SJ et al. The ‘adenobody’ approach to viral targeting: specific and enhanced adenoviral gene delivery Gene Therapy 1997 4: 1004–1012
Gu DL et al. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice Cancer Res 1999 59: 2608–2614
Douglas JT et al. Targeted gene delivery by tropism-modified adenoviral vectors Nat Biotechnol 1996 14: 1574–1578
Wickham TJ et al. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types Nat Biotechnol 1996 14: 1570–1573
Patterson S, Russell, WC . Ultrastructural and immunofluorescence studies of early events in adenovirus-HeLa cell interactions J Gen Virol 1983 64: 1091–1099
Wang K et al. Adenovirus internalization and infection required dynamin J Virol 1998 72: 3455–3458
Li E et al. Adenovirus endocytosis via αv integrins requires phosphoinositide-3-OH-kinase J Virol 1998 72: 2055–2061
Li E et al. Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases J Virol 1998 72: 8806–8812
Dedhar S et al. Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling Trends Cell Biol 1999 9: 319–323
Giancotti FG et al. Integrin signaling Science 1999 285: 1028–1032
Hotamisligil GS et al. Tumor necrosis factor alpha inhibits signaling from the insulin receptor Proc Natl Acad Sci USA 1994 91: 4854–4858
Guo D, Donner DB . Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes J Biol Chem 1996 271: 615–618
Pomerance M et al. Effects of growth factors on phosphatidylinositol-3-kinase in astroglial cells J Neurosci Res 1995 40: 737–746
Kotani K et al. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling EMBO J 1994 13: 2313–2321
Hu P et al. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors Mol Cell Biol 1992 12: 981–990
Stewart PL et al. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization EMBO J 1997 16: 1189–1198
Felding-Habermann B et al. Involvement of integrin αv gene expression in human melanoma tumorigenicity J Clin Invest 1992 89: 2018–2022
Von Seggern DJ et al. A helper-independent adenovirus vector with E1,E3, and fiber deleted: Structure and infectivity of fiberless particles J Virol 1999 73: 1601–1608
Legrand V et al. Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber J Virol 1999 73: 907–919
Davison E et al. Integrin α5β1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16 J Virol 1997 71: 6204–6207
Summerford C et al. αvβ5 integrin: a co-receptor for adeno-associated virus type 2 infection Nature Med 1999 5: 78–82
Dramsi S, Cossart P . Intracellular pathogens and the actin cytoskeleton Annu Rev Cell Dev Biol 1998 14: 137–166
Uematsu Y . A novel and rapid cloning method for the T-cell receptor variable region sequences Immunogenetics 1991 34: 174–178
Mathias P et al. Interactions of soluble recombinant integrin αvβ5 with human adenoviruses J Virol 1998 72: 8669–8675
Xiang J et al. Genetic engineering of a recombinant fusion possessing anti-tumor F(ab′) 2 and tumor necrosis factor J Biotechnol 1997 53: 3–12
Acknowledgements
This research was supported by grants RO1 EY11431 and RO1 HL54352 from the National Institutes of Health and from SFP1089 from the Novartis Corporation. E Li was supported by NIH T32 AI07354. We would like to thank Catalina Hope and Joan Gausepohl for preparation of this manuscript. This is manuscript No. 12865 -IMM at The Scripps Research Institute.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, E., Brown, S., Von Seggern, D. et al. Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery. Gene Ther 7, 1593–1599 (2000). https://doi.org/10.1038/sj.gt.3301271
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301271
Keywords
This article is cited by
-
Delivery of Viral Vectors to Tumor Cells: Extracellular Transport, Systemic Distribution, and Strategies for Improvement
Annals of Biomedical Engineering (2006)
-
Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses
Gene Therapy (2004)
-
Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells
Cancer Gene Therapy (2004)